No abstract available.
Sputum* ; Tuberculosis, Pulmonary*

No abstract available.
Adult* ; Diverticulum* ; Fistula* ; Humans ; Traction*

No abstract available.
Tuberculosis, Pulmonary*

BACKGROUND AND OBJECTIVES: For patients with bilateral carotid artery stenosis, simultaneous bilateral carotid endarterectomy is rarely performed due to a higher perioperative risk for death and strokes. We assessed the immediate and long-term outcomes of simultaneous bilateral carotid stenting (SBCS) for internal carotid stenosis in patients at high surgical risk. MATERIALS AND METHODS: We analyzed 10 patients who underwent SBCS for de novo stenoses of both internal carotid arteries (ICA). Included were those who had 60% to 99% stenosis of extracranial ICAs irrespective of neurologic symptoms and had more than 2 risk factors of Mayo grade III (medical risks) or IV (neurologic risks). RESULTS: The patients had a mean age of 67+/-7 years. Technical success was achieved in all lesions. The mean percent diameter stenosis was reduced from 79+/-13% to 8+/-8%. A total of 21 Wallstents were deployed at 20 lesions. One patient had a minor stroke just after the procedure which was completely resolved with local injection of urokinase. There were no deaths, major strokes or myocardial infarctions during the 30 day follow-up. Six months imaging studies were available on all 9 eligible patients with 18 lesions by duplex sonography and angiography. Late clinical follow-up at a mean of 15.1+/-8.1 months revealed no occurrence of neurologic event or death. CONCLUSION: SBCS is feasible, safe and effective to treat bilateral de novo ICA stenoses in patients at high surgical risk. The procedure, however, is investigational and more experience is required to define its role in the treatment of this patient population.
Angiography ; Carotid Artery, Internal* ; Carotid Stenosis* ; Constriction, Pathologic ; Endarterectomy, Carotid ; Follow-Up Studies ; Humans ; Myocardial Infarction ; Neurologic Manifestations ; Risk Factors ; Stents* ; Stroke ; Urokinase-Type Plasminogen Activator

No abstract available.

No abstract available.
Hematoma*

BACKGROUND: Coronary perfusion pressure(CPP) is the most important factor for the success of cardiopulmonary resuscitation(CPR). Therefore, CPP must be optimized during the resuscitation. The purpose of this study is to investigate the effects of isosorbide dinitrate(Isoket(R)) on CPP during CPR. METHODS: 10 Korean dogs were divided into two groups: Group I(N=5) was resuscitated with infusion of isosorbide dinitrate(1 microgram /kg/min) and Group II(N=5) was resuscitated without using isosorbide dinitrate. Following CPR, the heart rate(HR), blood pressure(BP), pulmonary capillary wedge pressure, cardiac output(CO), CPP and endocardial viability ratio(EVR) were measured repeatedly. RESULTS: The changes in HR were not significantly different between the two groups but systolic and diastolic BP, CO, CPP and EVR were well maintained in group 1. CONCLUSIONS: These results suggest that the usual dosage of isosorbide dinitrate is effective in improving CPP and EVR on CPR after impending cardiac arrest.
Animals ; Cardiopulmonary Resuscitation* ; Dogs ; Heart ; Heart Arrest ; Isosorbide Dinitrate ; Isosorbide* ; Perfusion* ; Pulmonary Wedge Pressure ; Resuscitation

No abstract available.
Nipples* ; Paget's Disease, Mammary*

No abstract available.
Carbon Dioxide* ; Carbon* ; Lasers, Gas*

BACKGROUND: Postoperative nausea and vomiting (PONV) is a common problem after general anesthesia. Compared with inhalational anesthetics, propofol has an antiemetic effect. We investigated the incidence of PONV after propofol and sevoflurane anesthesia for strabismus surgery in pediatric patients, and evaluated the effectiveness of ondansetron prophylaxis after sevoflurane anesthesia. METHODS: A healthy pediatric patients (n = 150) were divided into three groups. Group P (n = 50) received intravenous anesthesia with propofol; Group S (n = 50), inhalational anesthesia with sevoflurane; and Group S-O (n = 50), inhalational anesthesia with sevoflurane and 0.06 mg/kg (up to 4 mg) of ondansetron. The occurrence and intensity of PONV were recorded. RESULTS: The incidence of PONV after sevoflurane-ondansetron anesthesia did not differ from that after propofol anesthesia, but was significantly attenuated. The recurrence of PONV after sevoflurane-ondansetron was lower than after propofol and sevoflurane anesthesia. CONCLUSIONS: Sevoflurane anesthesia with ondansetron prophylaxis may be a good alternative to propofol in terms of avoiding PONV.
Anesthesia ; Anesthesia, General ; Anesthesia, Intravenous ; Anesthetics ; Antiemetics ; Humans ; Incidence ; Ondansetron ; Pediatrics* ; Postoperative Nausea and Vomiting* ; Propofol* ; Recurrence ; Strabismus*